125 related articles for article (PubMed ID: 18176075)
1. Norcantharidin ameliorates proteinuria, associated tubulointerstitial inflammation and fibrosis in protein overload nephropathy.
Liu FY; Li Y; Peng YM; Ye K; Li J; Liu YH; Duan SB; Ling GH; Xu XQ; Zhou LT
Am J Nephrol; 2008; 28(3):465-77. PubMed ID: 18176075
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin attenuates tubulointerstitial fibrosis in rat models with diabetic nephropathy.
Li Y; Chen Q; Liu FY; Peng YM; Hou T; Duan SB; Li J; Luo JH; Sun L; Ling GH
Ren Fail; 2011; 33(2):233-41. PubMed ID: 21332346
[TBL] [Abstract][Full Text] [Related]
3. [Localized expressing tendency of nuclear transcription factor kappa-B, pro-fibrosis genetic factors and fibronectin mRNA in renal tissues in proteinuria overload nephrotic young rats].
Ma H; Li XH; Li Z; Yin HQ; Wang XH; Li WW; Li H; Liu Q
Zhonghua Er Ke Za Zhi; 2005 Nov; 43(11):814-8. PubMed ID: 16316526
[TBL] [Abstract][Full Text] [Related]
4. [Protective effects of Hirsutella sinensis on renal interstitial fibrosis: experiment with rat model of chronic aristolochic acid nephropathy].
Zhu YF; Chen YP; Rui HL; Dong HR; Hu Z
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2667-71. PubMed ID: 18167239
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of norcantharidin against renal tubulointerstitial fibrosis.
Yun QS; Bao YX; Jiang JB; Guo Q
Pharmacol Rep; 2024 Apr; 76(2):263-272. PubMed ID: 38472637
[TBL] [Abstract][Full Text] [Related]
6. Norcantharidin, a protective therapeutic agent in renal tubulointerstitial fibrosis.
Li Y; Ge Y; Liu FY; Peng YM; Sun L; Li J; Chen Q; Sun Y; Ye K
Mol Cell Biochem; 2012 Feb; 361(1-2):79-83. PubMed ID: 21956672
[TBL] [Abstract][Full Text] [Related]
7. Protein Phosphatase 2A Inhibiting β-Catenin Phosphorylation Contributes Critically to the Anti-renal Interstitial Fibrotic Effect of Norcantharidin.
Xiao Z; Wen L; Zeng D; Yin D; Zhou X; Tang C; Li Y
Inflammation; 2020 Jun; 43(3):878-891. PubMed ID: 31940108
[TBL] [Abstract][Full Text] [Related]
8. NCTD Prevents Renal Interstitial Fibrosis via Targeting Sp1/lncRNA Gm26669 Axis.
Tian J; Xiao Z; Wei J; Shan Y; Zeng D; Tao Y; Fang X; Tang C; Chen X; Li Y
Int J Biol Sci; 2021; 17(12):3118-3132. PubMed ID: 34421354
[TBL] [Abstract][Full Text] [Related]
9. TLR2-MyD88-NF-κB pathway is involved in tubulointerstitial inflammation caused by proteinuria.
Ding LH; Liu D; Xu M; Wu M; Liu H; Tang RN; Ma KL; Chen PS; Liu BC
Int J Biochem Cell Biol; 2015 Dec; 69():114-20. PubMed ID: 26485683
[TBL] [Abstract][Full Text] [Related]
10. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic acid regulates IκBα and prevents tubulointerstitial injury in kidney.
Takase O; Hishikawa K; Kamiura N; Nakakuki M; Kawano H; Mizuguchi K; Fujita T
Eur J Pharmacol; 2011 Nov; 669(1-3):128-35. PubMed ID: 21871881
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
Wang S; Denichilo M; Brubaker C; Hirschberg R
Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
[TBL] [Abstract][Full Text] [Related]
13. [Norcantharidin potentialize the chemosensitivity of adriamycin through the NF-κB/IκBα signaling pathway].
Song XN; Du HF; Yu LJ; Meng YF; Lü HY; Sun LX; Meng JB; Zhang JQ
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):809-13. PubMed ID: 22339951
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of connective tissue growth factor in a rat model of chronic allograft nephropathy.
Tu Z; Shi Y; Wang J; Bao J; Bu H
Nephrology (Carlton); 2007 Apr; 12(2):166-71. PubMed ID: 17371341
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats.
Han KH; Kang YS; Han SY; Jee YH; Lee MH; Han JY; Kim HK; Kim YS; Cha DR
Kidney Int; 2006 Jul; 70(1):111-20. PubMed ID: 16723984
[TBL] [Abstract][Full Text] [Related]
16. [Expression of connective tissue growth factor in renal interstitial fibrosis after ureteral obstruction and effects of rapamycin thereupon: experiment with rats].
Sun B; Xing CY; He WC; Wang NN; Yu XB; Zhao XF; Qian J; Yang JW; Liu J; Wang XY
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):562-6. PubMed ID: 17459212
[TBL] [Abstract][Full Text] [Related]
17. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.
Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939
[TBL] [Abstract][Full Text] [Related]
18. Protective Effect of Norcantharidin on Collagen-Induced Arthritis Rats.
Shen HB; Huo ZJ; Bai YJ; He XJ; Li CH; Zhao YK; Guo QQ
Chin J Integr Med; 2018 Apr; 24(4):278-283. PubMed ID: 29264841
[TBL] [Abstract][Full Text] [Related]
19. Anti-renal interstitial fibrosis effect of norcantharidin is exerted through inhibition of PP2Ac-mediated C-terminal phosphorylation of Smad3.
Luo HW; Yin DD; Xiao Z; Wen L; Liao YJ; Tang CY; Zeng D; Xiao HT; Li Y
Chem Biol Drug Des; 2021 Feb; 97(2):293-304. PubMed ID: 32896083
[TBL] [Abstract][Full Text] [Related]
20. Exogenous bone morphogenetic protein-7 fails to attenuate renal fibrosis in rats with overload proteinuria.
Ikeda Y; Jung YO; Kim H; Oda T; López-Guisa J; Maruvada R; Diamond DL; Martin KJ; Wing D; Cai X; Eddy AA
Nephron Exp Nephrol; 2004; 97(4):e123-35. PubMed ID: 15331933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
